Author

A. J. Gehring

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Mehrotra· 1 shared A. Sayad· 1 shared C. Chua· 1 shared D. A. Winer· 1 shared D. Furman· 1 shared D. K. H. Wong· 1 shared D. Mahamed· 1 shared F. J. Alibhai· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Mehrotra

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 12, 2023

B Cells Promote T Cell Immunosenescence and Mammalian Aging Parameters

S. Khan, M. Chakraborty, F. Wu…·D. A. Winer

The paper identifies B cells as drivers of T cell immunosenescence and aging, showing that targeting B cells with CD20 antibodies can reverse age-related T cell dysfunction.

DOI 10.1101/2023.09.12.556363

mousebulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 28, 2023

Liver-specific Inflammatory Signatures Predict Clinically Significant Liver Damage.

C. Chua, D. Mahamed, S. Nkongolo…·A. J. Gehring

The paper identifies liver-specific inflammatory signatures that precede clinically significant liver damage in CHB patients after NA withdrawal.

DOI 10.1101/2023.02.28.530386

humanscRNA-seq

𝕏 PostBluesky